Sabinsa has been granted US patent #7,063,861, for Garcitrin®, a branded ingredient that offers effective weight management support. The patent, entitled "Bio-available Composition of Natural and Synthetic HCA" describes the use of the natural bioactive hydroxycitric acid (HCA) in combination with garcinol in weight management.
HCAis a well researched compound, clinically proven to support weight management. However, because HCA is poorly absorbed into target cells, it is ineffective alone as an inhibitor for adenosine triphosphate citratelyase, a key enzyme in body fat formation.
Sabinsa's proprietary ingredient Garcitrin combines HCA with garcinol, a polyisoprenylated benzophenone isolated from Garcinia cambogia and Garcinia indica fruits.
The combination of calcium salt HCA and garcinol reduces fatty acid and lipid synthesis and improves lean body mass more effectively than HCA alone, as observed in a controlled clinical study. Garcitrin supported a reduction in total body weight, body mass index, body fat and perceived appetite level, as well as increase lean body mass and body water content, much more efficiently than HCA alone.